• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP ITALIA S.R.L. ANNULOFLEX MITRAL ANNULOPLASTY RING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP ITALIA S.R.L. ANNULOFLEX MITRAL ANNULOPLASTY RING Back to Search Results
Model Number AF-832
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problems Mitral Insufficiency (1963); No Information (3190)
Event Date 09/13/2019
Event Type  Injury  
Manufacturer Narrative
At this time there is no indication of a device malfunction.The site reported a failed repair with no further details.The root cause cannot be established at this time.If further information is received the case will be reassessed.
 
Event Description
On (b)(6) 2019 a patient received an annuloflex af-832 mitral repair ring.The manufacturer was notified that the repair attempt failed and the device was explanted.No other information was provided.
 
Event Description
On (b)(6) 2019 a patient received an annuloflex af-832 mitral repair ring.The manufacturer was notified that the repair attempt failed and the device was explanted.No other information was provided.The manufacturer received the following updated information from the site regarding the event on (b)(6) 2020.Preoperative assessment and indications for surgery.83 year old male patient with a history of cad s/p lad pcl/stent, htn, hld, ckd, bph, and hypothyroidism.Patient presented with acute pulmonary edema with sob and orthopnea.He was found to have cute diastolic hf due to severe mr, torn chordae and partial flail of p2.(nyha iii) he was diuresed at osh with improvement in cardiopulm symptoms and transferred to ppmc on (b)(6) 2019.Symptoms developed two to three days prior to admission.Tee performed revealed ef 60-65%, severe mr, flailed mitral leaflevp2.There was moderate leaflet calcification of the area under the flail segment.Cardiac catheterization revealed no obstructive coronary artery disease greater than 50%.The lad stent was widely patent.There was severe calcification in the coronaries.There was severe mr on v-gram with good lv function.At time of operation intraoperative tee confirmed the above.Operation: on valve analysis there was relatively sparse leaflet tissue, with a relatively small anteriorly leaflet.There was a flail area of p2 (fibroelastic deficiency).The flail segment was calcified at its base.The valve was repaired attempted by placing 2 gortex chords to the p2 segment and implanting the annuloflex af-832 mitral repair ring).The patient was weaned from cardiopulmonary bypass without difficulty.Repeat tee showed a central jet at p2 of mild to moderate mitral regurgitation, no sam and no change in lv function.Probable cause was excess calcium on the leaflet.Valve replacement was performed due to patients age.The ring was removed, and the valve was replaced with a # 25 st.Jude mosaic porcine prosthesis (model # e100"25m-00, serial# (b)(6)).The patient was again weaned from cp bypass without difficulty.Repeat tee showed a well functioning prosthesis, no paravalvular leak and no change in lv function.
 
Manufacturer Narrative
On (b)(6) 2019 a patient received an annuloflex af-832 mitral repair ring.The manufacturer was notified that the repair attempt failed and the device was explanted.No other information was provided.The manufacturer received the following updated information from the site regarding the event on (b)(6) 2020.Preoperative assessment and indications for surgery.83 year old male patient with a history of cad s/p lad pcl/stent, htn, hld, ckd, bph, and hypothyroidism.Patient presented with acute pulmonary edema with sob and orthopnea.He was found to have cute diastolic hf due to severe mr, torn chordae and partial flail of p2.(nyha iii) he was diuresed at osh with improvement in cardiopulm symptoms and transferred to ppmc on (b)(6) 2019.Symptoms developed two to three days prior to admission.Tee performed revealed ef 60-65%, severe mr, flailed mitral leaflevp2.There was moderate leaflet calcification of the area under the flail segment.Cardiac catheterization revealed no obstructive coronary artery disease greater than 50%.The lad stent was widely patent.There was severe calcification in the coronaries.There was severe mr on v-gram with good lv function.At time of operation intraoperative tee confirmed the above.Operation: on valve analysis there was relatively sparse leaflet tissue, with a relatively small anteriorly leaflet.There was a flail area of p2 (fibroelastic deficiency).The flail segment was calcified at its base.The valve was repaired attempted by placing 2 gortex chords to the p2 segment and implanting the annuloflex af-832 mitral repair ring).The patient was weaned from cardiopulmonary bypass without difficulty.Repeat tee showed a central jet at p2 of mild to moderate mitral regurgitation, no sam and no change in lv function.Probable cause was excess calcium on the leaflet.Valve replacement was performed due to patients age.The ring was removed, and the valve was replaced with a # 25 st.Jude mosaic porcine prosthesis (model # e100"25m-00, serial# (b)(6)).The patient was again weaned from cp bypass without difficulty.Repeat tee showed a well functioning prosthesis, no paravalvular leak and no change in lv function.Based on the information received the event was not attributable to any device related malfunctions and the removal of the annuloflex ring was a result of pre-existing patient factors which required a procedural change from a repair to a full valve replacement.To ensure the device met all standards and requirements a complete manufacturing and material records review for the device has been performed.The results confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.The root cause of the reported event is thus deemed to be, cause cannot be traced to device : adverse event related to patient condition fields changed: b4, b5, g4, g7, h2, h6.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ANNULOFLEX MITRAL ANNULOPLASTY RING
Type of Device
MITRAL ANNULOPLASTY RING
Manufacturer (Section D)
SORIN GROUP ITALIA S.R.L.
strada crescentino snc
saluggia, vc
MDR Report Key9413728
MDR Text Key169217038
Report Number3005687633-2019-00266
Device Sequence Number1
Product Code KRH
UDI-Device Identifier08022057013637
UDI-Public(01)08022057013637(240)AF-832(17)231231
Combination Product (y/n)N
PMA/PMN Number
K023185
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 03/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/31/2023
Device Model NumberAF-832
Device Catalogue NumberAF-832
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 11/05/2019
Initial Date FDA Received12/04/2019
Supplement Dates Manufacturer Received03/06/2020
Supplement Dates FDA Received03/18/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age83 YR
-
-